16 Dec Anosmia News from Monell: SCENTinel 1.0 and More

Posted at 15:37h in Newsletters by
  • SCENTinel 1.0.  Monell scientists evaluated whether self-administering SCENTinel can discriminate between individuals with smell loss (anosmics) and average smell ability (normosmics).
  • Meet STANA.  The first smell and taste patient advocacy group in North America.
  • New Look for Monell Sites.  Visit the 2019-2020 Annual Report and our new website.
  • Ongoing Research. Building on previous work by Monell scientist Dr. Hong Wang on the relationship between inflammation in the nasal cavity and age-related smell loss.
  • Industrial Design Student Requests Help from Anosmics. 

Download the full Anosmia Newsletter here.